![Gabriela Gruia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriela Gruia
Directeur/Membre du Conseil chez
TSCAN THERAPEUTICS, INC.
Fortune : 648 $ au 31/07/2026
Profil
Gabriela Gruia is the founder of Dr. Gruia Consulting LLC, founded in 2021, serving as Principal since its founding.
Current jobs include Director at NETRIS Pharma SAS since 2023, Independent Director at TScan Therapeutics, Inc. since 2021, and Independent Director at Aprea Therapeutics, Inc. since 2023.
Former jobs include Independent Director at Tessa Therapeutics Ltd, Independent Director at Molecular Templates, Inc. from 2023 to 2024, SVP & Head-Global Regulatory Affairs at Novartis Oncology, Inc. from 2008 to 2020, and Chief Development Officer at Ichnos Glenmark Innovation, Inc. from 2020 to 2021.
Education includes a doctorate from Medicine & Pharmacy Carol Davila University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 1 045 ( 0,01% ) | 648 $ | 31/07/2026 | |
| 20/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Gabriela Gruia
| Sociétés | Poste | Début |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/05/2021 |
| APREA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/05/2023 |
Gabriela Gruia Consulting LLC | Fondateur | 01/01/2021 |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Gabriela Gruia
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Directeur Technique/Scientifique/R&D | 02/10/2023 |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Corporate Officer/Principal | 01/01/2021 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/02/2020 |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Directeur/Membre du Conseil | - |
Formation de Gabriela Gruia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology Develops targeted therapies for the treatment of cancer | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Medicine & Pharmacy Carol Davila University of
 Medicine & Pharmacy Carol Davila University of Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Gabriela Gruia Consulting LLC |
